Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of TEYI Pharmaceutical Group, is a Chinese pharmaceutical company based in Haikou, Hainan. Founded in 1992, the company specializes in the research, development, and manufacturing of a wide range of pharmaceutical products, including chemical drugs and traditional Chinese medicines. Its portfolio covers various therapeutic areas such as gastrointestinal health, infectious diseases, metabolic disorders, and musculoskeletal conditions. Notable products include Omeprazole enteric-coated capsules, Azithromycin granules, and the recently approved Glucosamine Sulfate capsules for osteoarthritis. The company operates GMP-certified manufacturing facilities and contributes significantly to the product pipeline and market presence of its parent company, TEYI Pharmaceutical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Haili Pharmaceutical.